NDC 67184-0574 – Ganirelix Acetate
Ganirelix Acetate 250 ug/.5mL · Injection, Solution · Subcutaneous
Product NDC67184-0574
Product details
- Brand name
- Ganirelix Acetate
- Generic name
- Ganirelix Acetate
- Labeler
- Qilu Pharmaceutical Co., Ltd.
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Marketing category
- ANDA · ANDA218855
- Marketed since
- May 15, 2025
- Listing expires
- December 31, 2026
- Pharmacologic class
- Gonadotropin Releasing Hormone Receptor Antagonist
Active ingredients
- Ganirelix Acetate 250 ug/.5mL
Uses, dosage, side effects and warnings for Ganirelix Acetate →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 67184-0574-1 | 1 BLISTER PACK in 1 CARTON (67184-0574-1) / 1 SYRINGE, GLASS in 1 BLISTER PACK / 1 mL in 1 SYRINGE, GLASS | May 15, 2025 |
Other Ganirelix Acetate products
- 68083-472 Ganirelix Acetate 250 ug/.5mL · Injection, Solution · Gland Pharma Limited
- 70748-274 Ganirelix Acetate 250 ug/.5mL · Injection, Solution · Lupin Pharmaceuticals, Inc.
- 71288-554 Ganirelix Acetate 250 ug/.5mL · Injection, Solution · Meitheal Pharmaceuticals Inc.
- 83301-0082 Ganirelix Acetate 250 ug/.5mL · Injection, Solution · Mullan Pharmaceutical Inc.
- 78206-138 Ganirelix Acetate 250 ug/.5mL · Injection, Solution · Organon LLC
- 0548-5001 Ganirelix Acetate 250 ug/.5mL · Injection · Amphastar Pharmaceuticals, Inc.
- 65219-028 Ganirelix Acetate 250 ug/.5mL · Injection · Fresenius Kabi USA, LLC
- 70700-327 Ganirelix Acetate 250 ug/.5mL · Injection · Xiromed LLC